Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis

Critical Care Medicine

Volumn 30, Issue 8, 2002, Pages 1729-1734

  Gando, Satoshi ^a   Kameue, Takashi ^a   Morimoto, Yuji ^a   Matsuda, Naoyuki ^a   Hayakawa, Mineji ^a   Kemmotsu, Osamu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Disseminated intravascular coagulation; Multiple organ dysfunction syndrome; Sepsis; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

ANTIBIOTIC AGENT; GABEXATE MESILATE; HEPARIN; LEUKOCYTE ELASTASE; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; INFECTION; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTOPENIA;

EID: 0036342697     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200208000-00009     Document Type: Article

References (30)

1. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock
2. Pathophysiology of disseminated intravascular coagulation in sepsis
3. Consumptive thrombohemorrhagic disorders
4. Tissue factor pathway of coagulation in sepsis
5. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions
6. Tissue factor inhibition and clinical trial of tissue factor pathway inhibitor in sepsis
7. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
8. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
9. The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and poly microbial intraabdominal sepsis
10. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
11. Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients
12. Proteinase inhibitors: α-macrogulobulins, serpins, and kunins
13. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: Role of neutrophil elastase
14. Initiation and regulation of tissue factor-dependent blood coagulation
15. APACHE II: A severity of disease classification system
16. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
17. An expanded definition of the adult respiratory distress syndrome
18. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome
19. Tissue factor and thrombin posttraumatic systemic inflammatory response syndrome
20. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma. Application of clinical decision analysis
21. Thrombocytopenia and prognosis in intensive care
22. Blunted rise in platelet count in critically ill patients is associated with worse outcome
23. Regulation of the extrinsic pathway system in health and disease: The role of factor VIIa and tissue factor pathway inhibitor
24. Tissue factor pathway inhibitor and the current concept of blood coagulation
25. Matrix metalloproteinases cleave tissue factor pathway inhibitor
26. "PMN-elastase assay": Enzyme immunoassay for human polymorphonuclear elastase complexed with alpha1-proteinase inhibitor
27. Plasma tissue factor: Its sensitive assay and characterization
28. Significant correlation between tissue factor and thrombin markers in trauma and septic patients
29. Tissue factor pathway inhibitor (TFPI) - An update
30. Another point of view on the mechanisms of thrombin generation during cardiopulmonary bypass